HILLEVAX INVESTOR NOTICE FROM FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Examines Price and Process Sufficiency in HilleVax, Inc. Sale Proposal - HLVX
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 19 2025
0mins
Source: Globenewswire
Investigation Announcement: Former Louisiana Attorney General Charles C. Foti, Jr. and Kahn Swick & Foti, LLC are investigating the proposed sale of HilleVax, Inc. to XOMA Royalty Corporation.
Transaction Details: Shareholders of HilleVax would receive $1.95 in cash per share along with a non-transferable contingent value right for potential additional payments.
Concerns Raised: KSF is assessing whether the offered consideration adequately reflects the company's value and if the sales process was appropriate.
Contact Information: Interested parties can reach out to KSF Managing Partner Lewis S. Kahn for discussions regarding their legal rights related to the sale.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
